Luc Boblet is a biotech serial entrepreneur with 15 years of experience in technology transfer, business development and corporate finance.
Before co-founding H-IMMUNE, Luc co-founded and ran Pathoquest, a start-up company spun out of Institute Pasteur, which develops disruptive unbiased NGS-based diagnostics in the field of infectious diseases. Under his guidance, Pathoquest raised two VC-backed rounds of financing, closed multiple strategic collaborations and corporate partnerships with leading pharma companies (CERBA Laboratories and Covance), and launched several clinicals trials in France and the U.S. From 2011 to 2015, he served on the board of directors of the BioAster Technological Research Institute.
Dr. Boblet holds a biotech engineering degree and a PhD in Virology from University Paris VII.
Michel Lenonetti is a Senior Scientist in immunology and team leader at Atomic Energy Commission (CEA) with over 20 years of experience in technological and industrial research collaborations.
Michel’s extensive research on the induction mechanisms of immune response led him to the breakthrough innovation known as IVI technology and its further derivation into a fully human antibody platform.
Dr. Leonetti holds a PhD in Immunology from University Paris XI is author of over 40 peer reviewed articles and patents.
Stéphane Postic has more than 15 years of experience in financial and corporate management in a variety of enterprises, bringing a high level of technical expertise in finance and corporate administration to the H-Immune management team.
Stéphane started his career in large international distribution companies, including financial management positions at Pinault-Printemps-Redoute and Carrefour, working in both France and the United Kingdom, where he was responsible for financial reporting and management of several business units.
Previously he served for almost six years as Chief Financial Officer at GENFIT, a biopharmaceutical company with offices in Lille, France and Cambridge, Massachusetts, where he oversaw the company’s IPO (Euronext: GNFT) and managed financial and business controls along with general administrative duties in close collaboration with other members of the senior management team.
Since that time he has utilized his extensive financial expertise as a Partner at QUARTAM, a consultancy providing financial services and strategic business advice to young innovative companies.
Stephane Postic holds a business graduate from the EM Lyon Business School.